Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Research Notes

Open Access

Na/K-ATPase assay in the intact mice lung subjected to perfusion

  • Cassiano Felippe Gonçalves-de-Albuquerque1Email author,
  • Patrícia Burth2,
  • Adriana Ribeiro Silva1,
  • IsabelMatos Medeiros de Moraes1,
  • FloraMagno Jesus de Oliveira1,
  • Ricardo Erthal Santelli3,
  • Aline Soares Freire3,
  • Mauricio Younes-Ibrahim4,
  • Hugo Caire de Castro-Faria-Neto1 and
  • Mauro Velho de Castro-Faria4
BMC Research Notes20147:798

https://doi.org/10.1186/1756-0500-7-798

Received: 28 April 2014

Accepted: 24 October 2014

Published: 15 November 2014

Abstract

Background

Among the characteristics of acute respiratory distress syndrome (ARDS) is edema formation and its resolution depends on pneumocyte Na/K-ATPase activity. Increased concentration of oleic acid (OA) in plasma induces lung injury by targeting Na/K-ATPase and, thus, interfering in sodium transport.

Findings

Presently, we adapted a radioactivity-free assay to detect Na/K-ATPase activity in perfused lung mice, comparing the inhibitory effect of ouabain and OA. We managed to perfuse only the lung, avoiding the systemic loss of rubidium. Rb+ incorporation into lung was measured by inductively coupled plasma optical emission spectrometry (ICP OES) technique, after lung tissue digestion. Na/K-ATPase activity was the difference between Rb+ incorporation with or without ouabain. Lung Na/K-ATPase was completely inhibited by perfusion with ouabain. However, OA caused a partial inhibition.

Conclusions

In the present work the amount of incorporated Rb+ was greater than seen in our previous report, showing that the present technique is trustworthy. This new proposed assay may allow researchers to study the importance of Na/K-ATPase activity in lung pathophysiology.

Keywords

LungNa/K-ATPaseInductively coupled plasma optical emission spectrometer

Background

The first description of acute respiratory distress syndrome (ARDS) appeared in 1967 [1]. One of the hallmarks of ARDS is increased alveolar capillary permeability leading to an interstitial and alveolar edema [2, 3]. The resolution of pulmonary edema and of lung inflammation are relevant factors for ARDS outcome [4]. Fluid management is one of the most important measures impacting ARDS, and a dynamic monitoring of the lung fluid balance seems to influence the clinical prognosis [5]. The removal of alveolar edema depends on the transport of salt and water across the alveolar epithelium into the lung interstitium via the basolaterally located Na/K-ATPase [68], which in turn drives the passive water flow toward the capillary net through the aquaporins [8].

Na/K-ATPase assay methods based on the incorporation of Rb+ by cultured cells [9], as well as the measurement of Rb+ efflux in the study of ion channels [10] have been described. The use of the non-radioactive Rb+ isotope as a K+ substitute avoids the manipulation of radioactive material. Rubidium, an element not found in biological systems, may be also measured by the atomic absorption spectrometry method.

We considered important to test the effect of the Na/K-ATPase inhibitors in a perfused lung model, which would allow the evaluation of the efficacy of these inhibitors in the intact organ.

As a first step, we propose a method to assay the Na/K-ATPase activity in absence or presence of ouabain and oleic acid (OA). In a previous report, we had developed a method for measuring Na/K-ATPase activity in intact guinea pig livers, based on the measurement of the uptake of non-radioactive Rb+ during in situ perfusion in the absence of K+ in the perfusion medium [11]. Differently now, we compared Na/K-ATPase inhibition by ouabain, a classical and specific Na/K-ATPase inhibitor, with OA, also known to induce lung injury in mice lung [1214]. OA targets this enzyme in vitro[15] and in vivo leading to lung injury [16, 17]. OA levels are elevated in pathological conditions such as severe leptospirosis [18] and sepsis [19], diseases evolving to ARDS.

In conclusion, in the present report we compared the inhibition caused by ouabain to that produced by OA in an in vivo perfused lung mice model.

Findings

Initially we defined the ideal perfusion flow rate based on our previous work with guinea pig liver, in which the ideal flow rate was 3 mL/min. We also defined a short rinsing period (5 min) because it was proved effective for efficient rinsing [11]. Besides, in vivo Rb+ quantification in mice lung showed a decrease of lung Na/K-ATPase activity observed 30 min after a single shot of KCl free-Hank’s containing ouabain or OA [16]. In the present work, we choose the time of 15 min of perfusion for two reasons: i) in 15 min, ouabain inhibition could already be detected; ii) mice lung is smaller than guinea pig liver, being quickly perfused with the same flow rate. A scheme of in situ perfusion is showed in Figure 1. Na/K ATPase activity was almost completely blocked by 1 mM ouabain in guinea pig liver [11]. Therefore, in the present work, we also used ouabain 1 mM to show a marked inhibition of rubidium incorporation in mice lung (Figure 2A).
Figure 1

Experimental scheme: H – heart, L – lung; ICP-OES - Inductively Coupled Plasma Optical Emission Spectrometer.

Figure 2

Inhibition of Rb + incorporation in lung tissue by ouabain and OA. (A) Mice were divided into four groups. Lungs of mice from the control group were perfused with Rb free-Hank’s. Mice lungs from the second group were perfused with KCl free-Hank’s solution. The third group was perfused with KCl free-Hank’s plus ouabain and mice lungs from the 4th group were perfused with KCl free-Hank’s plus tris-oleate. Rb+ incorporation in lungs was measured after 15 min by ICP-OES in digested lung tissues. Results are expressed in μmol Rb+ incorporated per h per g of wet tissue ± SEM of 5 to 13 animals in each group. (B) Calculated percent of ouabain sensitive inhibition of Na/K-ATPase based on data from Figure 2A (the difference between Rb+ incorporation in absence and in presence of ouabain was considered as 100% enzyme activity). Ouabain insensitive Rb+ incorporation represents the amount of Rb+ into the tissue that enters through potassium channels and passive diffusion. The experiment was repeated twice. *P <0.002, compared to controls.

Oleic acid is used to induce lung injury [17] and it is associated to increased mortality and complication in patients with high levels of this free fatty acid in blood. OA also targets Na/K-ATPase [2022]. Previous results from our group in in vitro experiments showed Na/K-ATPase inhibition near 58% by OA [21]. Our present data show that the Na/K-ATPase inhibition by OA was approximately the half as compared to ouabain, as assessed by our Rb+ incorporation assay (Figure 2B).

Discussion

After Rb+ incorporation, a short rinse with saline appeared to remove the perfusion medium from the vascular space efficiently. In guinea pig liver it would take less than one minute to change all the intravascular liquid at a perfusion rate of 3 ml/min. Assuming that mice lung is a lot less heavy (weighing 200 mg – 350 mg), most of Rb+ would be removed from lung vascular system after 5 min.

Our previous work with liver showed a direct proportionality between ouabain-sensitive Rb+ uptake and incubation time up to 60 min, evidencing that ATP concentration in the tissue remained at acceptable levels for the enzyme function [11]. We perfused during a shorter period and it is worth to mention that the enzyme was not short of ATP. We assume that the ouabain dose completely blocked the rubidium incorporation that depends on ATPase because of Na/K-ATPase inhibition. It is important to note that data from in vivo experiments using higher ouabain concentrations killed the majority of the animals [16]. The ouabain-insensitive Rb+ measurement can be assigned not only to an incomplete tissue-washing procedure but also to a passive Rb+ incorporation through K+ channels.

The main advantage of the present modified method is that it increases the sensitivity for Rb+ quantification: rubidium incorporation was about 20 times higher than seen in our previous work [16].

Inflammation induced by OA intravenous administration resembles ARDS in many morphological, histological and physiological aspects [14]. In this regard, ARDS patients or at-risk patients who subsequently develop ARDS have increased plasma OA concentrations [23]. Sepsis patients at risk to develop ARDS [24] present markedly increased plasma OA levels compared to healthy volunteers [25]. In most ARDS patients, the edema resolution and Na/K-ATPase activity are impaired and patients having reduced ability to clear edema have increased mortality [6, 26, 27], suggesting that Na/K-ATPase is an important player in the pathophysiology of ARDS [28]. Because of the great importance of OA in several pathologies, we decide to compare its effect on Na/K-ATPase activity with the lung Na/K-ATPase inhibition caused by ouabain. Our previous report showed that the ouabain and OA had similar in vivo effect on the Na/K-ATPase [16], probably because we used higher OA doses. However, Na/K-ATPase is not the sole target for OA. Since ouabain was more effective in lung Na/K-ATPase inhibition than OA, we suggest that OA should have additional targets in cell membranes, such as fatty acid receptor and fatty acid transporters [2933].

It is worth to point out that, comparing with our previous communication [16], lung perfusion allows more Rb+ to be incorporated in lung tissue. In the present communication, as compared to our previous work, we noted a higher sensitivity in Rb+ detection allowing differential detection between oleic acid and ouabain on Rb+ incorporation. The fact that OA can cause lung injury with alveoli disruption has been well characterized in animal models [34]. This could explain why lung injury induced by OA is more severe than that one induced by ouabain. Nevertheless, lung injury has an important correlation with Na/K-ATPase inhibition [16].

Conclusions

This proposed assay is a reliable and powerful tool for researchers to test the compounds targeting lung Na/K-ATPase activity and, consequently, to study the impact of Na/K-ATPase in lung physiology and pathology under conditions similar to those found in the intact organ.

Methods

Animals

All experiments were conducted in male Swiss mice (25 – 35 g) at age 6 to 10 weeks old obtained from the Oswaldo Cruz Foundation breeding unit. The animals were lodged at 22°C with a 12 h light/dark cycle and free access to food and water. Animal housing conditions and all experimental procedures conformed to institutional regulations and were in accordance with the National Institute of Health guidelines on animal care. The institutional animal welfare committee approved all of the procedures described here under license numbers 002–08 and LW-36/10 (CEUA/FIOCRUZ).

Preparation of oleate solutions

OA (Sigma-Aldrich, St. Louis, MO) was used to prepare a 100 mM tris-oleate solution as described in Gonçalves de Albuquerque [35]. Briefly, after weighting and water addition, sodium hydroxide was slowly added until the pH reached 13.0. The solution was maintained at 37°C and the mixture was sonicated until complete oleate solubility. Then, the pH was carefully adjusted to 7.6 with dilute hydrochloric acid. The working oleate solution was prepared by appropriate dilutions of the 100 mM solution with sterile saline (PBS) pH 7.5. The working oleate solutions were tested for the presence of LPS by the limulus amebocyte lysate test (LAL), which was provided by the Instituto Nacional de Controle de Qualidade em Saúde (INCQS)-Fundação Oswaldo Cruz, showing negative results.

Experimental design and ouabain and oleic acid perfusion

Mice were divided in four groups. We used 5 to 13 animals per group. The control group was perfused with Rb+ free-Hank’s solution. Each animal in the second group was perfused with KCl free-Hank’s solution with Rb+. The third group received the same KCl free-Hank’s with Rb+plus ouabain, and finally the last group was perfused with KCl free-Hank’s Rb+plus tris-oleate.

After complete anesthesia obtained by intraperitoneal injection of 10 mg/kg of xylazin and 100 mg/Kg of ketamin dissolved in sterile saline, the thoracic cavity was opened and the left heart ventricle was cannulated using a scalpel. At the same time, right atrial appendage was cut and left open. The lung was covered with a piece of gauze immersed in saline to prevent excessive water loss by evaporation. The perfusion medium was a modified Hank’s solution (pH 7.4) containing 136.9 mM NaCl, 5.4 mM RbCl, 0.8 mM MgSO4, 5 mM NaHCO3, 0.33 mM Na2HPO4, 0.44 mM NaH2- PO4, 5 mM Hepes, 1.5 mM CaCl2, 3 mM glucose and heparin (1000 UI/l) both in the absence and in the presence of ouabain or tris-oleate. The perfusion medium was continuously oxygenated by bubbling a 95% O2, 5% CO2 gas mixture in a homemade aerating chamber. Tubing carrying this medium remained immersed in a temperature-regulated water bath adjusted to maintain the perfused lung effluent temperature at 36.5–37°C. The flow rate was 3 mL/min based on our previous results with liver [11]. The flow rate was regulated by an infusion pump (LifeMed model LF2001, Life Med Ltd., Brazil). At the end of the perfusion, physiological saline at 2–4°C was perfused at this same flow rate.

Na/K-ATPase assay in mouse lungs based on Rb+ incorporation

After the rinsing procedure, the entire lung was removed, rinsed with cold saline and gently dried with filter paper. Then, 0.5 g of the lung tissue was transferred to glass tubes (250 mm × 22 mm) for digestion and 3 mL of 65% nitric acid was added. This mixture was heated in a Tecnal apparatus (model TE040125. Tecnal Ind., Brazil) at 100°C for 30 min – at this point some H2O2 drops were added to increase the speed of tissue digestion. The temperature was raised to 150°C for the next 15 min, and then to 175°C for more 15 min and finally at 200°C until the digest was completely clear. After cooling, the volume was adjusted to 15 mL with distilled water. Digested tissue samples were used to quantify Rb+[11]. Briefly, for the rubidium assay we used an iCAP 6300 dual view Inductively Coupled Plasma Optical Emission Spectrometer (ICP OES) (Thermo Scientific, Cambridge, England) equipped with a Mira Mist nebulizer. Cyclonic spray chamber and a CCD detector. The operational software iTEVA 2.0 was used to data acquisition. All determinations were done in axial view and using analytical curves with nine rubidium standard solutions prepared by adequate dilution of 1,000 mg L−1 analytical grade Rb stock standard solution (Quimlab Química & Metrologia®, Jardim Califórnia, Jacareí, São Paulo, Brasil) until the desired concentrations using ultrapure water from a Direct 8 Milli-Q® system (Merck Millipore, Billerica, Massachusetts, EUA). The linearity of calibration curves was checked in the analytical range 0.012–0.12 μmol/L, and was not tested beyond this value. Samples having higher concentrations were diluted and re-analyzed. Results were expressed as μmol of Rb+ incorporated per 30 min per gram of tissue.

Statistical analysis

Results were analyzed using “one way” ANOVA followed by Newman-Keuls (software GraphPad Prism 5.0). Values with p <0.05 were considered significant. Data are presented as mean ± SEM.

Abbreviations

OA: 

Oleic acid

ARDS: 

Acute respiratory distress syndrome

ICP-OES: 

Inductively coupled plasma optical emission spectrometer.

Declarations

Acknowledgements

This work received financial support from Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Programa Estratégico de Apoio à Pesquisa em Saúde (PAPES)-FIOCRUZ and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). We acknowledge the institutions where this work was accomplished, as follows: Fundação Oswaldo Cruz (FIOCRUZ), Universidade do Estado do Rio de Janeiro (UERJ) and Universidade Federal Fluminense (UFF).

Authors’ Affiliations

(1)
Instituto Oswaldo Cruz, Laboratório de Imunofarmacologia, FIOCRUZ
(2)
Departamento de Biologia Celular e Molecular, Instituto de Biologia, Universidade Federal Fluminens
(3)
Departamento de Química Analítica, Universidade Federal do Rio de Janeiro
(4)
Departamento de Medicina Interna, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro

References

  1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet. 1967, 2: 319-323.PubMedView ArticleGoogle Scholar
  2. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS: Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012, 307: 2526-2533.PubMedGoogle Scholar
  3. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 2000, 342: 1334-1349. 10.1056/NEJM200005043421806.PubMedView ArticleGoogle Scholar
  4. Pierrakos C, Karanikolas M, Scolletta S, Karamouzos K, Velissaris D: Acute respiratory distress syndrome: pathophysiology and therapeutic options. J Clin Med Res. 2012, 4: 7-16.PubMedPubMed CentralGoogle Scholar
  5. Neamu RF, Martin GS: Fluid management in acute respiratory distress syndrome. Curr Opin Crit Care. 2013, 19: 24-30. 10.1097/MCC.0b013e32835c285b.PubMedView ArticleGoogle Scholar
  6. Sznajder JI, Factor P, Ingbar DH: Invited review: lung edema clearance: role of Na(+)-K(+)-ATPase. J Appl Physiol. 2002, 93: 1860-1866.PubMedView ArticleGoogle Scholar
  7. Vadasz I, Morty RE, Olschewski A, Konigshoff M, Kohstall MG, Ghofrani HA, Grimminger F, Seeger W: Thrombin impairs alveolar fluid clearance by promoting endocytosis of Na+, K + −ATPase. Am J Respir Cell Mol Biol. 2005, 33: 343-354. 10.1165/rcmb.2004-0407OC.PubMedView ArticleGoogle Scholar
  8. Matthay MA, Folkesson HG, Clerici C: Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev. 2002, 82: 569-600.PubMedView ArticleGoogle Scholar
  9. Gill S, Gill R, Wicks D, Despotovski S, Liang D: Development of an HTS assay for Na+, K + −ATPase using nonradioactive rubidium ion uptake. Assay Drug Dev Technol. 2004, 2: 535-542. 10.1089/adt.2004.2.535.PubMedView ArticleGoogle Scholar
  10. Terstappen GC: Functional analysis of native and recombinant ion channels using a high-capacity nonradioactive rubidium efflux assay. Anal Biochem. 1999, 272: 149-155. 10.1006/abio.1999.4179.PubMedView ArticleGoogle Scholar
  11. Dos Santos MC, Burth P, Younes-Ibrahim M, Goncalves CF, Santelli RE, Oliveira EP, de Castro Faria MV: Na/K-ATPase assay in the intact guinea pig liver submitted to in situ perfusion. Anal Biochem. 2009, 385: 65-68. 10.1016/j.ab.2008.10.046.View ArticleGoogle Scholar
  12. Wang HM, Bodenstein M, Markstaller K: Overview of the pathology of three widely used animal models of acute lung injury. Eur Surg Res. 2008, 40: 305-316. 10.1159/000121471.PubMedView ArticleGoogle Scholar
  13. Davidson KG, Bersten AD, Barr HA, Dowling KD, Nicholas TE, Doyle IR: Lung function, permeability, and surfactant composition in oleic acid-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol. 2000, 279: L1091-L1102.PubMedGoogle Scholar
  14. Shuster DP: ARDS: clinical lessons from the oleic acid model of acute injury. Am J Respir Crit Care Med. 1994, 149: 245-260. 10.1164/ajrccm.149.1.8111590.View ArticleGoogle Scholar
  15. Swarts HG, Schuurmans Stekhoven FM, De Pont JJ: Binding of unsaturated fatty acids to Na+, K(+)-ATPase leading to inhibition and inactivation. Biochim Biophys Acta. 1990, 1024: 32-40. 10.1016/0005-2736(90)90205-3.PubMedView ArticleGoogle Scholar
  16. Goncalves-de-Albuquerque CF, Burth P, Silva AR, de Moraes IM, de Jesus Oliveira FM, Santelli RE, Freire AS, Bozza PT, Younes-Ibrahim M, de Castro-Faria-Neto HC, de Castro-Faria MV: Oleic acid inhibits lung Na/K-ATPase in mice and induces injury with lipid body formation in leukocytes and eicosanoid production. J Inflamm (Lond). 2013, 10: 34-10.1186/1476-9255-10-34.View ArticleGoogle Scholar
  17. Gonçalves-de-Albuquerque C, Silva A, Burth P, Moraes I, Oliveira F, Younes Ibrahim M, Santos M, D’Ávila H, Bozza P, Castro Faria Neto H, Castro Faria M: Oleic acid induces lung injury in mice through activation of the ERK pathway. Mediators Inflamm. 2012, 2012: 11-Google Scholar
  18. Burth P, Younes-Ibrahim M, Santos MC, Castro-Faria Neto HC, de Castro Faria MV: Role of nonesterified unsaturated fatty acids in the pathophysiological processes of leptospiral infection. J Infect Dis. 2005, 191: 51-57. 10.1086/426455.PubMedView ArticleGoogle Scholar
  19. Bursten SL, Federighi DA, Parsons P, Harris WE, Abraham E, Moore EE, Moore FA, Bianco JA, Singer JW, Repine JE: An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome. Crit Care Med. 1996, 24: 1129-1136. 10.1097/00003246-199607000-00011.PubMedView ArticleGoogle Scholar
  20. Vadasz I, Morty RE, Kohstall MG, Olschewski A, Grimminger F, Seeger W, Ghofrani HA: Oleic acid inhibits alveolar fluid reabsorption: a role in acute respiratory distress syndrome?. Am J Respir Crit Care Med. 2005, 171: 469-479. 10.1164/rccm.200407-954OC.PubMedView ArticleGoogle Scholar
  21. Burth P, Younes-Ibrahim M, Goncalez FH, Costa ER, Faria MV: Purification and characterization of a Na+, K + ATPase inhibitor found in an endotoxin of Leptospira interrogans. Infect Immun. 1997, 65: 1557-1560.PubMedPubMed CentralGoogle Scholar
  22. Tamura M, Kuwano H, Kinoshita T, Inagami T: Identification of linoleic and oleic acids as endogenous Na+, K + −ATPase inhibitors from acute volume-expanded hog plasma. J Biol Chem. 1985, 260: 9672-9677.PubMedGoogle Scholar
  23. Quinlan GJ, Lamb NJ, Evans TW, Gutteridge JM: Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. Crit Care Med. 1996, 24: 241-246. 10.1097/00003246-199602000-00010.PubMedView ArticleGoogle Scholar
  24. Matthay MA, Ware LB, Zimmerman GA: The acute respiratory distress syndrome. J Clin Invest. 2012, 122: 2731-2740. 10.1172/JCI60331.PubMedPubMed CentralView ArticleGoogle Scholar
  25. Mayer K, Gokorsch S, Fegbeutel C, Hattar K, Rosseau S, Walmrath D, Seeger W, Grimminger F: Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med. 2003, 167: 1321-1328. 10.1164/rccm.200207-674OC.PubMedView ArticleGoogle Scholar
  26. Sznajder JI: Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive. Am J Respir Crit Care Med. 2001, 163: 1293-1294. 10.1164/ajrccm.163.6.ed1801d.PubMedView ArticleGoogle Scholar
  27. Ware LB, Matthay MA: Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001, 163: 1376-1383. 10.1164/ajrccm.163.6.2004035.PubMedView ArticleGoogle Scholar
  28. Morty RE, Eickelberg O, Seeger W: Alveolar fluid clearance in acute lung injury: what have we learned from animal models and clinical studies?. Intensive Care Med. 2007, 33: 1229-1240. 10.1007/s00134-007-0662-7.PubMedView ArticleGoogle Scholar
  29. Rayasam GV, Tulasi VK, Davis JA, Bansal VS: Fatty acid receptors as new therapeutic targets for diabetes. Expert Opin Ther Targets. 2007, 11: 661-671. 10.1517/14728222.11.5.661.PubMedView ArticleGoogle Scholar
  30. Hirasawa A, Hara T, Katsuma S, Adachi T, Tsujimoto G: Free fatty acid receptors and drug discovery. Biol Pharm Bull. 2008, 31: 1847-1851. 10.1248/bpb.31.1847.PubMedView ArticleGoogle Scholar
  31. Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M: Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem. 2005, 280: 13285-13291. 10.1074/jbc.M410922200.PubMedView ArticleGoogle Scholar
  32. Febbraio M, Hajjar DP, Silverstein RL: CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest. 2001, 108: 785-791. 10.1172/JCI14006.PubMedPubMed CentralView ArticleGoogle Scholar
  33. Xu S, Jay A, Brunaldi K, Huang N, Hamilton JA: CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but Not transport across the plasma membrane. Biochemistry. 2013, 52: 7254-7261. 10.1021/bi400914c.PubMedView ArticleGoogle Scholar
  34. Sun Y, Yang R, Zhong JG, Fang F, Jiang JJ, Liu MY, Lu J: Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in rats. Crit Care. 2009, 13: R31-10.1186/cc7737.PubMedPubMed CentralView ArticleGoogle Scholar
  35. de Albuquerque CF G, Burth P, Younes Ibrahim M, Garcia DG, Bozza PT, Castro Faria Neto HC, Castro Faria MV: Reduced plasma nonesterified fatty acid levels and the advent of an acute lung injury in mice after intravenous or enteral oleic acid administration. Mediators Inflamm. 2012, 2012: 601032-Google Scholar

Copyright

© Gonçalves-de-Albuquerque et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement